サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1454136

医療用医薬品市場：タイプ別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）

Ethical Pharmaceuticals Market, By Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 301 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
医療用医薬品市場：タイプ別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）
出版日: 2024年03月04日
発行: AnalystView Market Insights
ページ情報: 英文 301 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

医療用医薬品の市場規模は2023年に65億9,009万米ドルとなり、2024年から2032年にかけてCAGR 12.90%で拡大すると予測されています。

医療用医薬品市場 - 市場力学

世界の不健康なライフスタイルの増加と高齢者人口の増加が市場の成長を促進すると予測されます。

高齢者は一般的にさまざまな健康問題を抱えており、関節炎、骨粗しょう症、認知症など、加齢に伴う症状を管理するために薬に頼っています。世界保健機関（WHO）は、2050年までに高齢者の80％が中低所得国に居住するようになると予測しています。食生活の乱れ、座りがちな生活、タバコやアルコールの使用などを特徴とする不健康なライフスタイルは、糖尿病、心血管疾患、呼吸器疾患などの慢性疾患の有病率増加の一因となっています。全米生物工学情報センターによると、運動不足率は世界的にばらつきがあり、米国や中東の43％から東南アジアの17％にまで及びます。また、新興国市場の急速な経済開拓は、製薬企業にとって市場プレゼンスを拡大する新たな機会を提供しています。しかし、薬価と償還に関する課題は、この市場の成長を阻害する可能性があります。

医療用医薬品市場 - 主な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024年～2032年）に約12.90%のCAGRで毎年成長すると推定されます。

タイプ別では、脂質調整剤は2023年に最大市場シェアを示すと予測されました。

エンドユーザー別では、製薬会社が2023年の主要タイプです。

地域別では、北米が2023年に主要な収益源となりました。

医療用医薬品市場 - セグメンテーション分析：

世界の医療用医薬品市場は、タイプ、エンドユーザー、地域に基づいてセグメント化されます。

市場はタイプ別に7つに区分され、脂質調整薬、ACE阻害薬、呼吸器官用薬、麻薬性鎮痛薬、利尿薬、カルシウム拮抗薬、ホルモン避妊薬、その他です。脂質調整剤は市場をリードするカテゴリーです。脂質調整剤の医療用医薬品市場は、心血管リスクに対処し、公衆衛生の成果を高めるために不可欠であるが、責任ある方法でその可能性を最大限に引き出すためには、数多くの倫理的および規制上の問題に対処しなければならないです。

市場はエンドユーザーによって、病院・診療所、および製薬会社の2つに区分されます。病院・診療所セクターが市場で最大のシェアを占めています。病院や診療所は、病気の診断や適切な薬の推奨において重要な役割を果たしています。開業医の処方箋が必要な医療用医薬品は、これらの施設で提供される治療プロトコルの重要な部分を形成しています。

医療用医薬品市場 - 地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカに広がっています。これらの地域は、事業活動に関与する国々に基づいてさらに区分されます。市場の成長は北米が支配的であると予想されるが、これは主に、特に新興諸国におけるヘルスケア支出の増加によるものです。北米の先進諸国はヘルスケアに多大なリソースを割いており、そのかなりの部分が医薬品に向けられています。医療費の増加は、医療用医薬品の需要を支えています。医療用医薬品は、様々な健康状態を管理し、患者の転帰を改善する上で重要な役割を果たしているからです。メディケアとメディケイドサービスセンターによると、米国の医療費は2022年に4.1％増加し、4兆5,000億米ドル、1人当たり1万3,493米ドルに達しました。医療費は国内総生産の17.3％を占めています。欧州は、安全で効果的な治療レジメンへの要望の高まりと、糖尿病、がん、血圧の罹患率の上昇を主因として、市場成長において2番目に大きな地域を占めています。

医療用医薬品市場 - 競合情勢：

製薬会社は、現在の治療法よりも優れた治療効果をもたらす新薬を生み出すため、研究開発に多大な資源を投入しています。イノベーションを通じて、企業は新たな薬物標的を特定し、より効率的な治療法を開発し、患者の転帰を向上させることができます。企業は画期的な製品をいち早く市場に投入し、特許による市場独占権を獲得しようと努力するため、競合が発生します。さらに、製薬会社は医療従事者、患者、介護者の間で製品の認知度を高めるため、マーケティングやブランド戦略に資金を割いています。マーケティング戦略には、消費者向け直接広告、医師教育、医療研修プログラム、科学会議の支援などが含まれます。

目次

第1章 医療用医薬品市場の概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 医療用医薬品の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 医療用医薬品産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 医療用医薬品市場：新型コロナウイルス感染症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 医療用医薬品の市場情勢

  • 医療用医薬品市場シェア分析（2023年）
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 医療用医薬品市場：タイプ別

  • 概要
    • セグメントシェア分析：タイプ別
    • 脂質調節剤
    • ACE阻害剤
    • 呼吸器官
    • 麻薬性鎮痛薬
    • 利尿薬
    • カルシウム拮抗薬
    • ホルモン避妊薬
    • その他

第8章 医療用医薬品市場：エンドユーザー別

  • 概要
    • セグメントシェア分析：エンドユーザー別
    • 病院とクリニック
    • 製薬会社
    • その他

第9章 医療用医薬品市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析 - 医療用医薬品業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Teva Pharmaceutical Industries Ltd.
    • Mylan Pharmaceuticals Inc
    • M Company
    • Accrux Ltd.
    • Access Pharmaceuticals Inc.
    • Novartis AG
    • Teikoku Pharma USA Inc
    • Hisamitsu Pharmaceutical
    • UCB
    • GlaxoSmithKline
    • Boehringer Ingelheim
    • Johnson &Johnson
    • Endo International
    • Purdue Pharma
    • Chrono Therapeutics
    • CeQur
    • Eli Lilly and Company
    • Merck &Co., Inc.
    • AstraZeneca
    • Bristol-Myers Squibb Company
    • Pfizer Inc.
    • Sanofi
    • Others

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data Types
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Ethical Pharmaceuticals Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Ethical Pharmaceuticals Market, by Type 2019-2032 (USD Million)
  • TABLE Ethical Pharmaceuticals Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Ethical Pharmaceuticals Market, by End-User 2019-2032 (USD Million)
  • TABLE Ethical Pharmaceuticals Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Ethical Pharmaceuticals Market, by Region 2019-2032 (USD Million)
  • TABLE North America Ethical Pharmaceuticals Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Ethical Pharmaceuticals Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Ethical Pharmaceuticals Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Ethical Pharmaceuticals Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Ethical Pharmaceuticals Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Ethical Pharmaceuticals Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Ethical Pharmaceuticals Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Ethical Pharmaceuticals Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Ethical Pharmaceuticals Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Ethical Pharmaceuticals Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Ethical Pharmaceuticals Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Ethical Pharmaceuticals Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Ethical Pharmaceuticals Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Ethical Pharmaceuticals Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Ethical Pharmaceuticals Market, by End-User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Ethical Pharmaceuticals Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-User segment market share analysis, 2023 & 2032
  • FIGURE End-User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Ethical Pharmaceuticals Market share and leading players, 2023
  • FIGURE Europe Ethical Pharmaceuticals Market share and leading players, 2023
  • FIGURE Asia Pacific Ethical Pharmaceuticals Market share and leading players, 2023
  • FIGURE Latin America Ethical Pharmaceuticals Market share and leading players, 2023
  • FIGURE Middle East and Africa Ethical Pharmaceuticals Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Ethical Pharmaceuticals Market share analysis by country, 2023
  • FIGURE Germany Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Ethical Pharmaceuticals Market share analysis by country, 2023
  • FIGURE India Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Ethical Pharmaceuticals Market share analysis by country, 2023
  • FIGURE Brazil Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Ethical Pharmaceuticals Market share analysis by country, 2023
  • FIGURE Saudi Arabia Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Ethical Pharmaceuticals Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV2317

REPORT HIGHLIGHT

Ethical Pharmaceuticals Market size was valued at USD 6,590.09 Million in 2023, expanding at a CAGR of 12.90% from 2024 to 2032.

Ethical Pharmaceuticals are established on the foundation of organizational ethics within the pharmaceutical industry, encompassing system compliance, accountability, and culture. These ethical standards are derived from legal mandates set by regulatory bodies. Ethical pharmaceuticals are tightly regulated substances used for diagnosing or treating diseases. The entire process of their development, testing, marketing, and distribution adheres to strict standards and regulations to guarantee their safety, effectiveness, and quality.

Ethical Pharmaceuticals Market- Market Dynamics

Growing unhealthy lifestyles and rising number of geriatrics around the world are projected to drive the growth of market

Elderly individuals commonly experience a range of health problems and rely on medications to manage age-related conditions, which may include arthritis, osteoporosis, and dementia, among others. The World Health Organization predicts that by 2050, 80% of older people will reside in low- and middle-income countries. Unhealthy lifestyles, characterized by poor eating habits, sedentary behaviors, and the use of tobacco and alcohol, contribute to the increasing prevalence of chronic diseases like diabetes, cardiovascular disorders, and respiratory ailments. According to the National Center for Biotechnology Information, physical inactivity rates vary globally, ranging from 43% in the United States of America and the Middle East to 17% in Southeast Asia. Additionally, the rapid economic development in emerging markets offers new opportunities for pharmaceutical companies to expand their market presence. However, challenges related to drug pricing and reimbursement may hinder the growth of this market.

Ethical Pharmaceuticals Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.90% over the forecast period (2024-2032)

Based on Type segmentation, Lipid Regulators was predicted to show maximum market share in the year 2023

Based on End-User segmentation, Pharmaceutical Companies was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Ethical Pharmaceuticals Market- Segmentation Analysis:

The Global Ethical Pharmaceuticals Market is segmented on the basis of Type, End-User and Region.

The market is segmented into seven categories according to Type: Lipid Regulators, ACE Inhibitors, Respiratory Agents, Narcotic Analgesics, Diuretics, Calcium Antagonists, Hormonal Contraceptives, and Others. Lipid Regulators are the leading category in the market. The ethical pharmaceuticals market for lipid regulators is essential in addressing cardiovascular risk and enhancing public health outcomes, however, it must address numerous ethical and regulatory issues to maximize its potential in a responsible manner.

The market is segmented into two categories according to their end-user: Hospitals & Clinics, Pharmaceutical Companies, and Others. The Hospitals & Clinics sector holds the largest share in the market. Hospitals and clinics play a crucial role in diagnosing diseases and recommending suitable medications. Ethical pharmaceuticals, which necessitate a prescription from a medical practitioner, form a significant part of the treatment protocols offered in these establishments.

Ethical Pharmaceuticals Market- Geographical Insights

Geographically, this market is spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is expected to be dominated by North America, primarily due to the increasing healthcare expenditures, especially in developed countries. Developed nations in North America allocate significant resources to healthcare, with a considerable portion of these resources directed towards pharmaceuticals. The rise in healthcare spending supports the demand for ethical pharmaceuticals, as these medications play a crucial role in managing various health conditions and improving patient outcomes. According to the Centers for Medicare & Medicaid Services, healthcare spending in the United States grew by 4.1 percent in 2022, reaching USD 4.5 trillion or USD 13,493 per person. Health spending accounted for 17.3 percent of the nation's Gross Domestic Product. Europe holds the second-largest region for market growth, primarily due to the increasing desire for safe and effective treatment regimens, as well as the rising incidences of diabetes, cancer, and blood pressure.

Ethical Pharmaceuticals Market- Competitive Landscape:

Pharmaceutical companies dedicate significant resources to research and development in order to create new medications that provide better therapeutic results compared to current treatments. Through innovation, companies can identify new drug targets, develop more efficient therapies, and enhance patient outcomes. Competition arises as companies strive to introduce groundbreaking products to the market swiftly and obtain market exclusivity via patents. Additionally, pharmaceutical companies allocate funds towards marketing and branding initiatives to increase product awareness among healthcare providers, patients, and caregivers. Marketing tactics may involve direct-to-consumer advertising, physician education, medical training programs, and support for scientific conferences.

Recent Developments:

Teva has made an announcement currently regarding its decision to strip its active-pharmaceutical ingredient section, known as TAPI. TAPI is a prominent player in the small-molecule API sector, employing around 4,300 individuals globally. The decision to divest TAPI will enable Teva to optimize its current and potential revenue streams, directing its focus towards growth and innovation through capital reallocation, and ultimately enhancing its ability to cater to the needs of patients.

March 13, 2023, The Ethisphere Institute has recently acknowledged 3M for its commitment to ethics and integrity in business practices and compliance for the 10th consecutive year. 3M is among the select few industrial companies worldwide to receive this prestigious recognition in the current year.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ETHICAL PHARMACEUTICALS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Teva Pharmaceutical Industries Ltd.

Mylan Pharmaceuticals Inc

3M Company

Accrux Ltd.

Access Pharmaceuticals Inc.

Novartis AG

Teikoku Pharma USA Inc

Hisamitsu Pharmaceutical

UCB

GlaxoSmithKline

Boehringer Ingelheim

Johnson & Johnson

Endo International

Purdue Pharma

Chrono Therapeutics

CeQur

Eli Lilly and Company

Merck & Co., Inc.

AstraZeneca

Bristol-Myers Squibb Company

Pfizer Inc.

Sanofi

Others

GLOBAL ETHICAL PHARMACEUTICALS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Lipid Regulators
  • ACE Inhibitors
  • Respiratory Agents
  • Narcotic Analgesics
  • Diuretics
  • Calcium Antagonists
  • Hormonal Contraceptives
  • Others

GLOBAL ETHICAL PHARMACEUTICALS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Pharmaceutical Companies
  • Others

GLOBAL ETHICAL PHARMACEUTICALS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Ethical Pharmaceuticals Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Ethical Pharmaceuticals Market Snippet by Type
    • 2.1.2.Ethical Pharmaceuticals Market Snippet by End-User
    • 2.1.3.Ethical Pharmaceuticals Market Snippet by Country
    • 2.1.4.Ethical Pharmaceuticals Market Snippet by Region
  • 2.2.Competitive Insights

3.Ethical Pharmaceuticals Key Market Trends

  • 3.1.Ethical Pharmaceuticals Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Ethical Pharmaceuticals Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Ethical Pharmaceuticals Market Opportunities
  • 3.4.Ethical Pharmaceuticals Market Future Trends

4.Ethical Pharmaceuticals Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Ethical Pharmaceuticals Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Ethical Pharmaceuticals Market Landscape

  • 6.1.Ethical Pharmaceuticals Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Ethical Pharmaceuticals Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.Lipid Regulators
    • 7.1.3.ACE Inhibitors
    • 7.1.4.Respiratory Agents
    • 7.1.5.Narcotic Analgesics
    • 7.1.6.Diuretics
    • 7.1.7.Calcium Antagonists
    • 7.1.8.Hormonal Contraceptives
    • 7.1.9.Others

8.Ethical Pharmaceuticals Market - By End-User

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 8.1.2.Hospitals & Clinics
    • 8.1.3.Pharmaceutical Companies
    • 8.1.4.Others

9.Ethical Pharmaceuticals Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Ethical Pharmaceuticals Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Ethical Pharmaceuticals Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Ethical Pharmaceuticals Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Ethical Pharmaceuticals Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Ethical Pharmaceuticals Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Ethical Pharmaceuticals Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Teva Pharmaceutical Industries Ltd.
    • 10.2.2.Mylan Pharmaceuticals Inc
    • 10.2.3.3M Company
    • 10.2.4.Accrux Ltd.
    • 10.2.5.Access Pharmaceuticals Inc.
    • 10.2.6.Novartis AG
    • 10.2.7.Teikoku Pharma USA Inc
    • 10.2.8.Hisamitsu Pharmaceutical
    • 10.2.9.UCB
    • 10.2.10.GlaxoSmithKline
    • 10.2.11.Boehringer Ingelheim
    • 10.2.12.Johnson & Johnson
    • 10.2.13.Endo International
    • 10.2.14.Purdue Pharma
    • 10.2.15.Chrono Therapeutics
    • 10.2.16.CeQur
    • 10.2.17.Eli Lilly and Company
    • 10.2.18.Merck & Co., Inc.
    • 10.2.19.AstraZeneca
    • 10.2.20.Bristol-Myers Squibb Company
    • 10.2.21.Pfizer Inc.
    • 10.2.22.Sanofi
    • 10.2.23.Others

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us